ABVC BioPharma(ABVC) - 2025 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2026 ABVC BIOPHARMA, INC. (Exact name of registrant as specified in its charter) | Nevada | 001-40700 | 26-0014658 | | --- | --- | --- | | (State or other jurisdiction | (Commission File Number) | (IRS Employer | | of incorporation) | | Identification No.) | | 44370 Old Warm Springs Blvd ...